SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerrys stronger-than-expected Q2 results and raised fiscal-year outlook are driving attention, alongside record QNX performance and its first Alloy Kore design win with Coretura. Traders are largely encouraged, but some question how quickly the design-win backlog will convert to revenue and are frustrated that the shares have not responded more strongly.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtions reported achievement of 30 entangled logical qubits operating together on its commercial Sqale system is the dominant catalyst, with traders emphasizing the distinction from research-only demonstrations. Many see it as a major quantum-computing milestone, while others question the error-correction details and note that formal news-wire confirmation was still awaited.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Rising Treasury yields and inflation concerns are fueling expectations of further Fed tightening and weighing on SPY. Traders are split between warning of a deeper selloff and viewing the pullback as a buying opportunity, with some pointing to possible Treasury purchases as support.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is under pressure as rising Treasury yields and expectations for further Fed tightening weigh on growth-heavy technology stocks, with oil and inflation concerns adding to the macro uncertainty. Traders are divided between expecting a deeper decline and buying the dip for another sharp rebound, with many also debating whether the volatile moves reflect algo-driven support.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves convertible-debt financing and potential share issuance are driving debate, with traders concerned about leverage and dilution weighing on the stock. Bulls counter that strong AI-compute demand, a large backlog and recent analyst upgrades support the companys expansion, leaving sentiment split amid volatile trading.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Goldman Sachs resumption of coverage at Buy, citing improving Amtagvi launch execution and gross margins, is drawing attention, with some traders welcoming the endorsement and others questioning the firms reversal. The community is also focused on the pending revenue-guidance update and upcoming NSCLC data, while some investors express frustration over the guidance delay.

Quantinuum Inc. is a quantum computing platform that offers solutions like hardware platforms, developer tools, application libraries and solution-targeted intellectual property (“IP”). The company was founded on January 20, 2026 and is headquartered in Broomfield, CO.

Quantinuum Inc. - Ordinary Shares - Class A

Quantinuum Inc.

Quantinuums finalized federal CHIPS funding award is drawing attention, alongside discussion of a possible Russell index addition and broader quantum-sector momentum. Traders are split between viewing government backing as validation and questioning the companys high valuation as shares remain volatile.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonalds shares are drawing attention after its investor-day outlook combined plans for substantial restaurant investment with expectations of persistent inflation, flat industry traffic and slightly negative U.S. sales for the quarter. Traders are divided between viewing the steep selloff as an oversold buying opportunity and seeing continued pressure from weak traffic, affordability concerns and execution challenges.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Positive registrational-trial results for Kyvernas CAR-T therapy miv-cel in stiff person syndrome, alongside encouraging longer-term myasthenia gravis data, are driving attention as traders weigh the potential BLA and first-in-autoimmune-CAR-T opportunity. Optimism over the clinical results is tempered by sharp post-news volatility, profit-taking, concerns about serious adverse events and speculation about a future offering.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is under pressure as Treasury yields climb to multi-year highs amid persistent inflation concerns, strong economic data and expectations for further Fed tightening; traders also point to heavy debt issuance and weak demand for long-term bonds. The conversation is largely bearish on further declines, though some traders are buying the dip or anticipating a rebound if yields ease or Treasury purchases support the long end.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Astrana Health (ASTH) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of +29.03% and -0.85%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Astrana Health, Inc. Reports Second Quarter 2026 Results

Astrana Health, Inc. Reports Second Quarter 2026 Results Astrana Health, Inc. Reports Second Quarter 2026 Results PR Newswire ALHAMBRA, Calif., Aug. 6, 2026 Company to Host Conference Call on Thursday, August 6, 2026, at 2:30 p.m. PT/5:30 p.m. ETReports revenue of $972.5 million, up 49...

U.S. Physical Therapy (USPH) Lags Q2 Earnings Estimates

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of -11.77% and +0.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call PR Newswire ALHAMBRA, Calif., July 14, 2026 ALHAMBRA, Calif., July 14, 2026 /PRNewswire/ -- Astrana...

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth PR Newswire ALHAMBRA, Calif., July 13, 2026 Names Daniel Rothman President of Physician Enterprise and Vishal Gupta Senior Vice President of Enterprise...

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year PR Newswire ALHAMBRA, Calif., July 13, 2026 All Eight ACOs Achieve Net Shared SavingsALHAMBRA, Calif., July 13...

Astrana Health, Inc. (ASTH) Surges 7.3%: Is This an Indication of Further Gains?

Astrana Health, Inc. (ASTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth

Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth PR Newswire ALHAMBRA, Calif., June 4, 2026 ALHAMBRA, Calif., June 4, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and...

Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results

Baird Lifts PT on Astrana Health (ASTH) Following Q1 Results...

Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It operates as an integrated healthcare delivery platform, providing services like Primary Care, Multi-Specialty Care, Immediate Care, Radiology, and Laboratory. The company was founded by Kenneth Sin and Thomas S. Lam in 1985 and is headquartered in Alhambra, CA.

Astrana Health Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$34.34
Prev Close	$35.11
Open	$33.08
Dividend Yield	0.00%
50-Day Moving Average	$38.34
Beta	0.73
Avg. Volume	452,555.00
PE Ratio	41.90

52-Week High	$51.60
52-Week Low	$18.08
Market Capitalization	$1.74B
EPS (Annual)	$0.4555
Price to Book	2.04
Revenue Per Employee	$1.06M

Feed

News

Sentiment

Earnings

Fundamentals

Info

ASTH Fundamentals